홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /화합물

(S)-Rabeprazole sodium

HCID 9821387
새 반응
인쇄
기본 정보이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
117976-90-6
표준 SMILES
COCCCOc1ccnc(CS(=O)c2nc3ccccc3[nH]2)c1C.[Na]
InChIKey
MLQSMKIAIQJZSZ-UHFFFAOYSA-N
분자식
C18H21N3NaO3S
평균 분자량
382.4 g/mol

이름 및 식별자

우선 이름
(S)-Rabeprazole sodium
영어명
Rabeprazole Sodium
분자식
C18H21N3O3S.Na
분자량
382.43

이름 및 동의어

(S)-Rabeprazole sodium2-[[[4-(3-methoxypropoxy)3-methyl-2-pyridinyl]-methyl]sulfinyl]-1H-benzimidazole sodium saltSCHEMBL491362MLQSMKIAIQJZSZ-UHFFFAOYSA-NIR1831252-[[[3-methyl-4-(3-methoxypropoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole sodium salt2-[[[4-(3-methoxypropoxy)-3-methyl-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole sodium salt2-[[[4-(3-methoxypropoxy)3-methyl-2-pyridinyl]-methyl]sulfinyl]-1Henzimidazole sodium salt2-{[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methylsulfinyl}-1h-benzimidazole sodium salt2-[4-(3-methoxy-propoxy)-3-methyl-pyridin-2-yl-methanesulfinyl]-1H-benzimidazole sodium saltRABEPRAZOLE SODIUMDexrabeprazole SodiuM
이름 더 보기
rebeprazole sodiumRabeprazole NaPARIETRABEPRAZOL SODIUMSODIUM RABEPRAZOLERabeprazole SodiuM USPRabeprazole sodium hydrate CRSParie

데이터베이스 식별자

CAS
117976-90-6
PubChem CID
9821387

물성

구조 계산 물성

극성 표면적
96.3 Ų
수소 결합 공여자 수
1
수소 결합 수용자 수
6
회전 가능 결합 수
8
무거운 원자 수
26
형식 전하
0
복잡도
440

물리화학적 성질

녹는점
140 · 140-141°C dec.
저장 조건
-20 °C · -20°C
용해도
2 O: · H2O: 가용성10mg/mL(투명 용액)
물리적 상태
가루
색상
흰색에서 베이지색
수용성
2 O: · H2O: 10mg/mL (clear solution)
Merck
14 · 14,8089
안정성
흡습성
InChI
InChI=1S/C18H20N3O3S.Na/c1-13-16(19-9-8-17(13)24-11-5-10-23-2)12-25(22)18-20-14-6-3-4-7-15(14)21-18;/h3-4,6-9H,5,10-12H2,1-2H3;/q-1;+1
InChIKey
KRCQSTCYZUOBHN-UHFFFAOYSA-N
SMILES
O=S(CC1C(C)=C(OCCCOC)C=CN=1)C1[N-]C2=CC=CC=C2N=1.[Na+]

화학적 성질

Rebeprazole sodium is White Crystalline Solid

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

안전 데이터

wgk
3
HS 번호
2933399090
Hazard Classifications
Acute Tox. 4 OralAquatic Chronic 4
스토리지 클래스
11 - Combustible Solids

화학 및 산업

응용 분야 · 3건

개요Rebeprazole sodium was launched as Pariet in Japan, its first market, for the treatment of peptic ulcers including gastric and duodenal ulcers. From 4-chloro- 2,3-dimethylpyridine N-oxide, a six step synthesis allows access to the basic skeleton after successive condensations. Rabeprazole, a structural analog of Omeprazole, the first compound to have been marketed in this class up to now, is reported to be a more potent inhibitor of gastric H+/K+-adenosine triphosphate (ATPase) ; a common mechanism of action of this chemical class involves the conversion at low pH to a reactive sulphonamide that itself binds to cysteine residues located on the enzyme. Moreover, rabeprazole showed an antibacterial activity against Helicobacter Pylori, with a MIC90 of 1.56 μg/ml. Rebeprazole sodium has a faster onset of action compared with omeprazole, but a shorter duration of action, being extensively and rapidly metabolized in several animal species. In clinical studies in patients with gastric ulcers, 10 and 20 mg rabeprazole sodium once-daily significantly inhibited basal and stimulated acid output. Rabeprazole is awaiting registration in the US for treatment of gastrooesophageal reflux disease (GORD) and other pathologic hypersecretory conditions including Zollinger-Ellison syndrome.

용도Rebeprazole sodium is a partially reversible gastric proton pump inhibitor. It belongs to a national second-class drug that can be used for the treatment of gastric ulcers. It can treat peptic ulcer, gastroesophageal reflux disease, zollinger-ellison syndrome and other diseases. This compound has the effects of anthelminthic, antiseptic, and expectorant. As an antibacterial and antifungal agent, it is effective against gram-positive and gram-negative bacteria, yeast and fungi.

일반 설명Rabeprazole sodium, 2[[[4-(3-methoxypropoxy)-3-methyl-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole sodium salt (Aciphex), is a white toslightly yellowish white solid. It is very soluble in water andmethanol, freely soluble in ethanol, chloroform, and ethyl acetate,and insoluble in ether and hexane. Rabeprazole is aweak base (pyridine N, pKa 4.53) and a weak acid (benzimidazoleN-H, pKa 0.62), faciliting sodium salt formation.Rabeprazole sodium is formulated as enteric-coated,delayed-release tablets to allow the drug to pass throughthe stomach relatively intact. After oral administration of20-mg peak plasma concentrations (Cmax) occur over arange of 2 to 5 hours (Tmax). Absolute bioavailability for a20-mg oral tablet of rabeprazole (vs. IV administration) isapproximately 52%. The plasma half-life ofrabeprazole ranges from 1 to 2 hours. The effects of foodon the absorption of rabeprazole have not been evaluated.Rabeprazole is 96% bound to human plasma proteins.Rabeprazole is extensively metabolized in the liver. Thethioether and sulfone are the primary metabolites measuredin human plasma resulting from CYP3A oxidation.Additionally, desmethyl rabeprazole is formed via the actionof CYP2C19. Approximately 90% of the drug is eliminatedin the urine, primarily as thioether carboxylic acidand its glucuronide and mercapturic acid metabolites. Theremainder of the dose is recovered in the feces. No unchangedrabeprazole is excreted in the urine or feces.

관련 반응

9건
반응 기록 만들기
HRID 411617 반응식
HRID 411617반응물로
HRID 411618 반응식
HRID 411618반응물로
HRID 567790 반응식
HRID 567790반응물로
HRID 567791 반응식
HRID 567791반응물로
HRID 567792 반응식
HRID 567792생성물로
HRID 1265042 반응식
HRID 1265042반응물로
HRID 2182872 반응식
HRID 2182872반응물로
HRID 2182876 반응식
HRID 2182876반응물로
이전1 / 2 페이지

화합물 노트

이 페이지에서기본 정보이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트

상·하류 제품 정보

상류 원료

2-{[4-(3-Methoxypropoxy)-3-methylpyridine-2-yl]methylthio}-1H-benzimidazole2-Chloromethyl-4-(3-methoxypropoxy)-3-methylpyridin[4-(3-메톡시프로폭시)-3-메틸-2-피리디닐]메탄올염산염1H-Benzoimidazole-2-thiol라베프라졸수산화나트륨에틸알코올